FANJ
AGIO icon

Financial Architects (New Jersey)’s Agios Pharmaceuticals AGIO Stock Holding History

Financial Architects (New Jersey)’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,000
Closed -$42K – 1557
2016
Q4 		$42K Hold
1,000
– – 0.01% 608
2016
Q3 		$53K Sell
1,000
-14
-1% -$610 0.01% 560
2016
Q2 		$42K Sell
1,014
-400
-28% -$19.8K 0.01% 575
2016
Q1 		$57K Buy
+1,414
New +$60.5K 0.02% 372
2015
Q3 		– Sell
-2,014
Closed -$224K – 224
2015
Q2 		$224K Hold
2,014
– – 0.08% 180
2015
Q1 		$190K Buy
2,014
+14
+0.7% +$1.57K 0.07% 197
2014
Q4 		$224K Buy
+2,000
New +$179K 0.1% 156

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return